Skip to main content
OpenTrials
Completed

NCT Number: NCT01952600

Empowering Patients On Choices for Renal Replacement Therapy (Aim 1)

The EPOCH-RRT study seeks to fill knowledge gaps by gaining more understanding of chronic kidney disease (CKD) patients' priorities; assessing the comparative benefits of hemodialysis (HD) versus peritoneal dialysis (PD), with respect to these priorities; and providing tailored information to assist patients with identifying the best dialysis modality fit for their own unique circumstances and perspectives.

The outcomes most relevant to patients ("patient-centered") extend beyond those traditionally assessed in clinical research, with the relative importance varying across patient groups. A tailored decision aid based on these findings can improve patient decision-making processes regarding choice of dialysis modality.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Empowering Patients On Choices for Renal Replacement Therapy (EPOCH-RRT)study seeks to identify factors that matter the most to patients with kidney disease and study how they are impacted by different types of dialysis. The inclusion of patients, caregivers, and patient advocacy organizations as research partners will assure that the study addresses questions of greatest relevance to patients facing the need for dialysis.

Aim One of EPOCH-RRT identifies outcomes that are most important to different groups of advanced CKD and dialysis patients through qualitative methods applied for conducting in-depth interviews.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals 18 years of age or older.
  • Individuals with advanced chronic kidney disease or on dialysis (in-center, hemodialysis, or peritoneal dialysis) for at least three months.

Exclusion criteria

  • Individuals under 18 years of age.
  • Individuals unable to provide informed consent.
  • Individuals who do not have chronic kidney disease.

Treatment and study plan

Primary outcomes

  1. Factors That Are Most Important to Patients

    Time frame: Baseline

    Differences in factors most important to patients were compared across chronic kidney disease, hemodialysis, and peritoneal dialysis patients.

Sponsors and collaborators

Lead sponsor

Arbor Research Collaborative for Health

Other

Collaborators

  • American Association of Kidney Patients
  • Henry Ford Health System
  • National Kidney Foundation, United States
  • Patient-Centered Outcomes Research Institute
  • University of Michigan

Registry information

Acronym: EPOCH-RRT

Important dates

Study start
2013
Primary completion
2013
Study completion
2015
First posted
Sep 30, 2013
Registry last updated
Sep 20, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.